USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	061847/0594			Pages:	4
		Recorded:	11/04/2022
Attorney Dkt #:	F053-0159TP
Conveyance:	CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT APPLICATION NUMBER 63/242,906 PREVIOUSLY RECORDED ON REEL 060439 FRAME 0279. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME.

Total properties: 19

Patent #:	7771718	Issue Dt:	08/10/2010	Application #:	10512181	Filing Dt:	05/18/2005
Publication #:	US20050233391	Pub Dt:	10/20/2005
Title:	SOLUBLE MIC POLYPEPTIDES AS MARKERS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER AND AUTOIMMUNE DISEASES OR CONDITIONS

Patent #:	7666417	Issue Dt:	02/23/2010	Application #:	10898003	Filing Dt:	07/23/2004
Publication #:	US20050158307	Pub Dt:	07/21/2005
Title:	METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES OR CONDITIONS

Patent #:	7959916	Issue Dt:	06/14/2011	Application #:	12108069	Filing Dt:	04/23/2008
Publication #:	US20090169552	Pub Dt:	07/02/2009
Title:	NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERP5

Patent #:	10040853	Issue Dt:	08/07/2018	Application #:	14343543	Filing Dt:	06/25/2014
Publication #:	US20140377266	Pub Dt:	12/25/2014
Title:	Methods and Compositions Involving NKG2D Inhibitors and Cancer

Patent #:	NONE	Issue Dt:		Application #:	16710988	Filing Dt:	12/11/2019
Publication #:	US20200115459	Pub Dt:	04/16/2020
Title:	METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES OR CONDITIONS

Patent #:	11821111	Issue Dt:	11/21/2023	Application #:	17097853	Filing Dt:	11/13/2020
Publication #:	US20210147832	Pub Dt:	05/20/2021
Title:	BARCODED INFLUENZA VIRUSES AND DEEP MUTATIONAL SCANNING LIBRARIES INCLUDING THE SAME

Patent #:	NONE	Issue Dt:		Application #:	17311211	Filing Dt:	06/04/2021
Publication #:	US20220025403	Pub Dt:	01/27/2022
Title:	REDUCED AND MINIMAL MANIPULATION MANUFACTURING OF GENETICALLY-MODIFIED CELLS

Patent #:	NONE	Issue Dt:		Application #:	17435610	Filing Dt:	09/01/2021
Publication #:	US20220154170	Pub Dt:	05/19/2022
Title:	PROTEIN RESIDUE MAPPING USING A COMBINATION OF DEEP MUTATIONAL SCANNING AND PHAGE DISPLAY HIGH THROUGHPUT SEQUENCING

Patent #:	11896655	Issue Dt:	02/13/2024	Application #:	17440597	Filing Dt:	09/17/2021
Publication #:	US20220280626	Pub Dt:	09/08/2022
Title:	CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS

Patent #:	NONE	Issue Dt:		Application #:	17441599	Filing Dt:	09/21/2021
Publication #:	US20220125814	Pub Dt:	04/28/2022
Title:	CANCER COMBINATION THERAPIES UTILIZING A NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITOR IN COMBINATION WITH A NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY PRECURSOR

Patent #:	NONE	Issue Dt:		Application #:	17624208	Filing Dt:	12/30/2021
Publication #:	US20220411472	Pub Dt:	12/29/2022
Title:	SELF-ASSEMBLING CIRCULAR TANDEM REPEAT PROTEINS WITH INCREASED STABILITY

Patent #:	NONE	Issue Dt:		Application #:	17758296	Filing Dt:	06/30/2022
Publication #:	US20230331804	Pub Dt:	10/19/2023
Title:	NANOPARTICLE SYSTEMS TO STIMULATE AND MAINTAIN IMMUNE SYSTEM RESPONSIVENESS AT TREATMENT SITES

Patent #:	NONE	Issue Dt:		Application #:	17767843	Filing Dt:	04/08/2022
Publication #:	US20230174618	Pub Dt:	06/08/2023
Title:	ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17907648	Filing Dt:	09/28/2022
Publication #:	US20230220103	Pub Dt:	07/13/2023			PCT #:	US2021025255
Title:	CHIMERIC ANTIGEN RECEPTORS TARGETING CD33

Patent #:	NONE	Issue Dt:		Application #:	17907655	Filing Dt:	09/28/2022
Publication #:	US20230144405	Pub Dt:	05/11/2023			PCT #:	US2021025220
Title:	HUMAN ANTI-CD33 ANTIBODIES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17907657	Filing Dt:	09/28/2022
Publication #:	US20230218669	Pub Dt:	07/13/2023			PCT #:	US2021025260
Title:	AUGMENTING ANTIGEN-NEGATIVE CELL DEATH IN ANTIGEN-TARGETED IMMUNOTHERAPIES

Patent #:	NONE	Issue Dt:		Application #:	17995085	Filing Dt:	09/29/2022
Publication #:	US20230151094	Pub Dt:	05/18/2023			PCT #:	US2021025248
Title:	CHIMERIC ANTIGEN RECEPTORS TARGETING CD33

Patent #:	NONE	Issue Dt:		Application #:	17995089	Filing Dt:	09/29/2022
Publication #:	US20230190810	Pub Dt:	06/22/2023			PCT #:	US2021025166
Title:	ANTI-CD33 ANTIBODIES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17995687	Filing Dt:	10/06/2022
Publication #:	US20230133243	Pub Dt:	05/04/2023			PCT #:	US2021026873
Title:	CONDITIONING REGIMENS FOR IN VIVO GENE THERAPY

Assignors

Exec Dt:

04/01/2022

Exec Dt:

04/01/2022

Assignee

1100 FAIRVIEW AVENUE NORTH

SEATTLE, WASHINGTON 98109

Correspondence name and address
	C. RACHAL WINGER, PH.D.
	601 WEST RIVERSIDE AVENUE, SUITE 1400
	SPOKANE, WA 99201

Search Results as of: 05/10/2024 06:57 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6